# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-027240
Filing Date
2025-12-11
Accepted
2025-12-11 16:05:49
Documents
61
Period of Report
2025-10-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1071033
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 17285
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 17121
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 6803
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 7035
| Complete submission text file | 0001493152-25-027240.txt |  | 5903390

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | bctx-20251031.xsd | EX-101.SCH | 40164
7 | XBRL CALCULATION FILE | bctx-20251031_cal.xml | EX-101.CAL | 42345
8 | XBRL DEFINITION FILE | bctx-20251031_def.xml | EX-101.DEF | 227111
9 | XBRL LABEL FILE | bctx-20251031_lab.xml | EX-101.LAB | 305384
10 | XBRL PRESENTATION FILE | bctx-20251031_pre.xml | EX-101.PRE | 277305
63 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1134737

Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-40101 | Film No.: 251565017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)